for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BIOQUAL, Inc.

BIOQ.PK

Latest Trade

34.30USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

28.00

 - 

41.00

As of on the Over The Counter ∙ Minimum 15 minute delay

Pricing

Previous Close
34.30
Open
--
Volume
--
3M AVG Volume
0.00
Today's High
--
Today's Low
--
52 Week High
41.00
52 Week Low
28.00
Shares Out (MIL)
0.89
Market Cap (MIL)
30.68
Forward P/E
--
Dividend (Yield %)
2.04

Next Event

Dividend For BIOQ.PK - 0.7000 USD

Latest Developments

More

Bioqual Inc declares dividend of $0.20 per share

Bioqual Inc Does Not Declare Dividend

BIOQUAL, Inc. Files Form 15 With SEC

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About BIOQUAL, Inc.

Bioqual, Inc. is a provider of research, development, consulting and testing/assay services to commercial clients and Government laboratories. The Company supports the National Institutes of Health by providing research services in the research areas of cancer, acquired immune deficiency syndrome (AIDS), hepatitis, influenza, immunology, transgenics, contraception, breeding and development of genetically defined animals, and neurobiology and behavior. The Company's research contracts consist of cancer virus studies, congenic animal development and monoclonal antibody research. The Company's research services include primate biology and medicine, small laboratory animal sciences, infectious disease research, in vitro laboratory services, environmental enrichment and behavior, good laboratory practice (GLP) studies, and partnerships for contracts and grants. The Company holds government contracts, which utilize the non-human primate model to study assorted human diseases.

Industry

Biotechnology & Drugs

Contact Info

4 Research Ct

+1.240.4047654

http://www.bioqual.com/

Executive Leadership

Mark G. Lewis

Chairman of the Board, President, Chief Executive Officer

David A. Newcomer

Chief Financial Officer

MITCH FRANKLIN

Vice President - Operations

Chander P. Sarma

Vice President - Facility Operations, Director - Information Technology

Nancy A. Madden

Vice President - Administration Operations, Biosafety Officer, Responsible Official

Key Stats

Price To Earnings (TTM)
11.14
Price To Sales (TTM)
0.78
Price To Book (MRQ)
1.25
Price To Cash Flow (TTM)
8.47
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
11.38
Return on Equity (TTM)
10.08

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up